AVROBIO
400 Technology Square, 10th Floor
Cambridge
Massachusetts
02139
United States
Website: http://www.avrobio.com/
Email: info@avrobio.com
12 articles about AVROBIO
-
AVROBIO Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
7/19/2019
AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the closing of its previously announced underwritten public offering of 7,475,000 shares of its common stock, including 975,000 shares of its common stock pursuant to the underwriters’ exercise in full of their option to purchase additional shares at the public offering price, less underwriting discounts and commissions.
-
AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
5/13/2019
AVROBIO, Inc. reported financial results for the first quarter ended March 31, 2019 and provided a business update.
-
AVROBIO, Inc. to Present at the Cowen and Company 39th Annual Health Care Conference
3/5/2019
AVROBIO, Inc. announced that the Company will present at the Cowen and Company 39th Annual Health Care Conference on Wednesday, March 13, 2019, at 8:40 a.m. ET at the Marriott Copley Place in Boston.
-
AVROBIO Appoints Ian Clark to Its Board of Directors
11/9/2017
Ian Clark, former CEO of Genentech, will join as an independent director effective immediately.
-
AVROBIO Expands Rare Disease Pipeline With Gene Therapy To Treat Cystinosis
10/4/2017
-
AVROBIO Appoints Katina Dorton As Chief Financial Officer
9/26/2017
-
AVROBIO Expands Rare Disease Pipeline With Gene Therapy To Treat Pompe Disease
9/21/2017
-
AVROBIO Expands Rare Disease Pipeline With Gene Therapy To Treat Gaucher Disease
3/22/2017
-
AVROBIO Expands Senior Management Team With Three Key Hires
11/9/2016
-
Mass. Startup AVROBIO Rakes in $25 Million Series A to Push Two Gene Therapy Clinical Trials
8/2/2016
-
Massachusetts' AVROBIO Awarded Johnson & Johnson Coveted J-Labs Incubator Space
5/13/2016
-
Cambridge Biotech AVROBIO Launches with Former MassBio Chair as CEO
2/22/2016